Auckland Biosciences
New Zealand–based manufacturer and exporter of animal-derived serum, plasma and related biological raw materials for cell culture, vaccine manufacture and research. The company operates multiple production sites, is ISO9001:2015 certified, applies government-mandated animal traceability systems, and focuses on converting animal by-products into high-value inputs for pharmaceutical and veterinary producers.
Industries
Nr. of Employees
small (1-50)
Products
Adult bovine serum
Serum derived from naturally clotted or defibrinated blood of disease‑free cattle bred and raised for human consumption in New Zealand.
Newborn calf serum
Serum derived from disease‑free newborn calves, intended for cell culture and research use.
Porcine and other species serum
Serum offerings derived from porcine and other species (ovine, caprine) sourced from New Zealand livestock.
Research and medical-grade animal by-products
Research and medical-grade animal organs and by-products sourced from disease-free New Zealand livestock, with further processing options available.
Adult bovine serum
Serum derived from naturally clotted or defibrinated blood of disease‑free cattle bred and raised for human consumption in New Zealand.
Newborn calf serum
Serum derived from disease‑free newborn calves, intended for cell culture and research use.
Porcine and other species serum
Serum offerings derived from porcine and other species (ovine, caprine) sourced from New Zealand livestock.
Research and medical-grade animal by-products
Research and medical-grade animal organs and by-products sourced from disease-free New Zealand livestock, with further processing options available.
Services
Production and export of animal-derived serum and plasma intended as raw materials for cell culture, veterinary vaccines and research institutions.
Additional downstream processing options, including sterile filtration and other value‑added processing, available on request to meet specific customer requirements.
Sourcing and certifying New Zealand origin raw materials with electronic traceability and government inspection to support customers seeking disease-free inputs.
Production and export of animal-derived serum and plasma intended as raw materials for cell culture, veterinary vaccines and research institutions.
Additional downstream processing options, including sterile filtration and other value‑added processing, available on request to meet specific customer requirements.
Sourcing and certifying New Zealand origin raw materials with electronic traceability and government inspection to support customers seeking disease-free inputs.
Expertise Areas
- Serum manufacturing for cell culture and vaccine production
- Bioprocessing and downstream purification
- Traceability and biosecurity compliance
- Quality management (ISO9001, HACCP) and export certification
Key Technologies
- Animal serum and plasma processing
- Sterile filtration
- Cleanroom manufacturing
- RFID-based animal traceability (NAIT integration)
News & Updates
Acquisition of an Australian serum business to expand capacity and market footprint; combined annual revenue reported.
Company update noting finalist placement in New Zealand International Business Awards and placement in the Deloitte Master of Growth Index 2023.
Profile of company growth from startup to multi-site exporter and discussion of strategy, talent and scaling challenges.
Acquired an Australian serum manufacturer to expand production and market reach; deal announced as near eight-figure value and increased combined annual revenue.
Awarded 'Best Emerging Business' at the New Zealand Trade & Enterprise International Business Awards 2018.
Recognised for innovation in converting primary industry waste into high-value export goods.
Acquisition of an Australian serum business to expand capacity and market footprint; combined annual revenue reported.
Company update noting finalist placement in New Zealand International Business Awards and placement in the Deloitte Master of Growth Index 2023.
Profile of company growth from startup to multi-site exporter and discussion of strategy, talent and scaling challenges.
Acquired an Australian serum manufacturer to expand production and market reach; deal announced as near eight-figure value and increased combined annual revenue.
Awarded 'Best Emerging Business' at the New Zealand Trade & Enterprise International Business Awards 2018.
Recognised for innovation in converting primary industry waste into high-value export goods.